A New Look at an Old Drug - Terbutaline

Subcutaneous terbutaline is clearly efficacious for those who have not responded to multiple beta agonist treatments. Subcutaneous terbutaline should be considered in patients who are receiving maximum pharmacological therapy.

Dr. Strauss and The Cleveland Allergy and Asthma Center published this paper in the The Journal of Allergy and Clinical Immunology.

The full article also available here in PDF format.